cold corpse, page-6

They hold 10% now and can't go above 20% without a formal takeover offer. They need 51% for control. It is up to the PSD board to consider its own shareholders and value the company fairly should an offer occur. Maybe you think that the board would just do Pfizer's bidding, but I'm not sure why they would. Paul Ashton has a huge stake in the company and naturally would want a good price for it.

(Apologies for some bad grammar in my previous post.)

Pezz